Please use this identifier to cite or link to this item:
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSasadeusz, Joe-
dc.contributor.authorGrigg, Andrew P-
dc.contributor.authorHughes, Peter D-
dc.contributor.authorLee Lim, Seng-
dc.contributor.authorLucas, Michaela-
dc.contributor.authorMcColl, Geoff-
dc.contributor.authorMcLachlan, Sue Anne-
dc.contributor.authorPeters, Marion G-
dc.contributor.authorShackel, Nicholas-
dc.contributor.authorSlavin, Monica-
dc.contributor.authorSundararajan, Vijaya-
dc.contributor.authorThompson, Alexander-
dc.contributor.authorDoyle, Joseph-
dc.contributor.authorRickard, James-
dc.contributor.authorDe Cruz, Peter-
dc.contributor.authorGish, Robert G-
dc.contributor.authorVisvanathan, Kumar-
dc.identifier.citationClinics in liver disease 2019; 23(3): 487-492-
dc.description.abstractCurrent recommendations concerning hepatitis C virus (HBV) reactivation are limited, with nearly all guidelines focused on its occurrence in patients with hematological malignancies or some solid tumors, who are treated with immunosuppressive therapies. Few of the guidelines address reactivation in patients receiving immunosuppression with organ transplants or treatment with any of the many immunosuppressive agents in use today for the treatment of multiple different diseases, or in patients receiving the direct-acting antivirals used in the treatment of hepatitis C virus (HCV). This article covers the immunology of HBV reactivation, mechanisms of viral clearance, and recommendations for screening and prophylaxis.-
dc.subjectHepatitis B immunology-
dc.subjectHepatitis B virus-
dc.titleScreening and Prophylaxis to Prevent Hepatitis B Reactivation: Introduction and Immunology.-
dc.typeJournal Article-
dc.identifier.journaltitleClinics in liver disease-
dc.identifier.affiliationUniversity of Western Australia, 35 Stirling Highway, Crawley, Western Australia 6009, Australiaen
dc.identifier.affiliationUniversity of California, San Francisco, S357 Parnassus Avenue, San Francisco, CA 94143, USAen
dc.identifier.affiliationIngham Institute, 1 Campbell Street, Liverpool, Sydney, New South Wales 2170, Australiaen
dc.identifier.affiliationVictorian Comprehensive Cancer Centre, 305 Grattan Street, Melbourne, Victoria 3000, Australiaen
dc.identifier.affiliationDepartment of Public Health, La Trobe University, Plenty Road, Bundoora, Victoria 3086, Australiaen
dc.identifier.affiliationBurnet Institute, 85 Commercial Road, Melbourne, Victoria 3004, Australiaen
dc.identifier.affiliationThe Alfred and Monash University, 85 Commercial Road, Melbourne, Victoria 3004, Australiaen
dc.identifier.affiliationSt Vincent's Hospital, 41 Victoria Street, Fitzroy, Victoria 3065, Australiaen
dc.identifier.affiliationPeter Doherty Institute for Infection and Immunity, Elizabeth Street, Melbourne, Victoria 3000, Australiaen
dc.identifier.affiliationOlivia Newton-John Cancer Research Institute, Heidelberg, Victoria, Australiaen
dc.identifier.affiliationDivision of Gastroenterology and Hepatology, Department of Medicine, Stanford University, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USAen
dc.identifier.affiliationUniversity of Queensland Oral Health Centre, 288 Herston Road, Queensland 4006, Australiaen
dc.identifier.affiliationRoyal Melbourne Hospital, 300 Grattan Street, Parkville, Victoria 3050, Australiaen
dc.identifier.affiliationUniversity of Melbourne, Grattan Street, Parkville, Victoria 3010, Australiaen
dc.identifier.affiliationNational University of Singapore, 21 Lower Kent Ridge Road, Singapore 119077, Singapore-
dc.type.austinJournal Article-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

checked on Jun 24, 2021

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.